University of South Florida

Digital Commons @ University of South Florida
Molecular Pharmacology & Physiology Faculty
Publications

Molecular Pharmacology & Physiology

2020

Effects of an Exogenous Ketone Supplement on Five‐Kilometer
Five Kilometer
Running Performance
Philip J. Prins
Grove City College

Andrew P. Koutnik
University of South Florida

Dominic P. D’Agostino
University of South Florida

Christopher Q. Rogers
University of South Florida, cqrogers@usf.edu

Jacob F. Seibert
Grove City College

See next page for additional authors
Follow this and additional works at: https://digitalcommons.usf.edu/mpp_facpub
Part of the Pharmacy and Pharmaceutical Sciences Commons

Scholar Commons Citation
Prins, Philip J.; Koutnik, Andrew P.; D’Agostino, Dominic P.; Rogers, Christopher Q.; Seibert, Jacob F.;
Breckenridge, Jillian A.; Jackson, Daniel S.; Ryan, Edward J.; Buxton, Jeffrey D.; and Ault, Dana L., "Effects
of an Exogenous Ketone Supplement on Five‐Kilometer Running Performance" (2020). Molecular
Pharmacology & Physiology Faculty Publications. 11.
https://digitalcommons.usf.edu/mpp_facpub/11

This Article is brought to you for free and open access by the Molecular Pharmacology & Physiology at Digital
Commons @ University of South Florida. It has been accepted for inclusion in Molecular Pharmacology &
Physiology Faculty Publications by an authorized administrator of Digital Commons @ University of South Florida.
For more information, please contact scholarcommons@usf.edu.

Authors
Philip J. Prins, Andrew P. Koutnik, Dominic P. D’Agostino, Christopher Q. Rogers, Jacob F. Seibert, Jillian A.
Breckenridge, Daniel S. Jackson, Edward J. Ryan, Jeffrey D. Buxton, and Dana L. Ault

This article is available at Digital Commons @ University of South Florida: https://digitalcommons.usf.edu/
mpp_facpub/11

Journal of Human Kinetics volume 72/2020, 115-127 DOI: 10.2478/hukin-2019-0114
Section II ‐ Exercise Physiology & Sports Medicine

115

Effects of an Exogenous Ketone Supplement
on Five‐Kilometer Running Performance

by
Philip J. Prins1, Andrew P. Koutnik2, Dominic P. D’Agostino2,
Christopher Q. Rogers2, Jacob F. Seibert1, Jillian A. Breckenridge1,
Daniel S. Jackson1, Edward J. Ryan3, Jeffrey D. Buxton1, Dana L. Ault1
Numerous oral ketone supplements are marketed with the claim that they will rapidly induce ketosis and
improve exercise performance. The purpose of this study was to assess exercise performance time and related
physiological, metabolic and perceptual responses of recreational endurance runners after ingestion of a commercially
available oral ketone supplement. Recreational endurance runners (n = 10; age: 20.8 ± 1.0 years; body mass: 68.9 ± 5.6
kg; height: 175.6 ± 4.9 cm) participated in a double-blind, crossover, repeated-measures study where they were
randomized to 300 mg.kg-1 body weight of an oral β-hydroxybutyrate-salt + Medium Chain Triglyceride (βHBsalt+MCT) ketone supplement or a flavor matched placebo (PLA) 60 min prior to performing a 5-km running time trial
(5KTT) on a treadmill. Time, HR, RPE, affect, RER, VO2, VCO2, and VE were measured during the 5-km run. The
Session RPE and affect (Feeling Scale) were obtained post-5KTT. Plasma glucose, lactate and ketones were measured at
baseline, 60-min post-supplement, and immediately post-5KTT. Plasma R-βHB (endogenous isomer) was elevated from
baseline and throughout the entire protocol under the βHB-salt+MCT condition (p < 0.05). No significant difference (58.3 ± 100.40 s; 95% CI: -130.12 – 13.52; p = 0.100) was observed between the βHB-salt+MCT supplement (1430.0 ±
187.7 s) and the PLA (1488.3 ± 243.8 s) in time to complete the 5KTT. No other differences (p > 0.05) were noted in
any of the other physiological, metabolic or perceptual measures.
Key words: ketosis, beta-hydroxybutyrate, dietary supplements, ergogenic aid.

Introduction
Ketosis is defined as elevated circulating
levels of ketone bodies (beta-hydroxybutyrate;
βHB, acetoacetate, acetone)]. Traditionally, ketosis
was achieved through fasting (Cahill, 2006), a
very low-carbohydrate ketogenic diet (VLCKD;
Phinney et al., 1980, 1983a, 1983b), or under
pathological conditions where insulin levels were
insufficient to prevent rapid ketogenesis (i.e.
mismanaged Type-1 Diabetes). The VLCKD
usually does not require caloric restriction and
was originally used as an effective dietary
replacement to fasting due to its overlapping

mechanisms (Newman and Verdin, 2017) for
epileptic seizures (Paoli et al., 2013). Currently,
the VLCKD is being explored as a metabolic tool
for other neurological disorders, obesity,
inflammatory disorders, Type-1 and -2 diabetes
mellitus, polycystic ovarian syndrome, and
cancer, amongst others (Koutnik et al., 2019; Paoli
et al., 2013; Poff et al., 2017; Stafstrom and Rho,
2012). The VLCKD has also been investigated for
longevity (Newman et al., 2017; Roberts et al.,
2017), along with cognitive and physical
performance (Newman et al., 2017; Volek et al.,
2016; Wilson et al., 2017).

- Department of Exercise Science, Grove City College, Grove City, PA, USA.
- Department of Molecular Pharmacology & Physiology, University of South Florida, USA.
3 - Department of Exercise Science, Chatham University, Pittsburgh, PA, USA.
Authors submitted their contribution to the article to the editorial board.
Accepted for printing in the Journal of Human Kinetics vol. 72/2020 in April 2020.
1
2

116

Effects of an exogenous ketone supplement on five-kilometer running performance

Emerging interest into the metabolic
influence of the VLCKD on athletic performance
began in the early 1980s where untrained and
trained athletes were able to maintain or improve
performance even in the absence of sufficient
dietary carbohydrates (Phinney et al., 1980,
1983a). Since that time, numerous studies have
explored the metabolic influence of diet on
aerobic (Zajac et al., 2014) and anaerobic
(Michalczyk et al., 2019; Paoli et al., 2012; Wilson
et al., 2017) performance to determine if major
shifts in substrate metabolism translate to altered
performance outcomes. However, lifestyle
modifications can be difficult for some to
maintain (Dansinger et al., 2005). Simultaneously,
interest has arisen to develop forms of ketone
bodies that can be exogenously administered.
Several exogenous ketone formulations have been
developed including R-βHB + S-βHB-salt (βHBsalt), βHB-salt + Medium Chain Triglycerides
(βHB-salt+MCT), and ketone esters, each of which
elevated circulating levels of ketone bodies when
orally administered (Kesl et al., 2016).
Comparative analysis in human subjects also
demonstrated the ability of exogenous ketones to
increase circulating ketone levels (Stubbs et al.,
2017). With the emergence of commercially
available
exogenous
ketone
formulations,
research has focused on exploring their use in
athletic performance (Cox et al., 2016; Evans and
Egan, 2018; Evans et al., 2018).
Exogenous ketone supplements that have
been used to manipulate metabolism in studies
investigating athletic performance can be divided
into two categories: Ketone Esters (Cox et al.,
2016; Evans and Egan, 2018; Leckey et al., 2017)
and βHB-salts (Evans et al., 2018; O'Malley et al.,
2017; Rodger et al., 2017; Waldman et al., 2018),
with the former inducing greater elevations in
βHB with correlated changes in systemic
metabolism (Stubbs et al., 2017). To date, one trial
showed exercise improvements (Cox et al., 2016),
three trials showed neutral effects (Evans and
Egan, 2018; Rodger et al., 2017; Waldman et al.,
2018), and two trials showed negative effects
using exogenous ketone supplementation (Leckey
et al., 2017; O'Malley et al., 2017). The likely
explanation for divergent findings is the
heterogeneity of exercise duration, task, and
intensity,
along
with
divergent
ketone
formulations and dose. Additionally, most trials
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involve cycling protocols (Cox et al., 2016; Leckey
et al., 2017; O'Malley et al., 2017; Waldman et al.,
2018; Rodger et al., 2017). Thus, further research
into the ergogenic or ergolytic potential of various
forms of ketone supplementation in other
performance contexts is warranted.
Interestingly, all βHB-salt trials done thus
far have utilized varying dosages (140-536
mg/kg), but resulted in similar elevations in RβHB (Evans et al., 2018; O'Malley et al., 2017;
Rodger et al., 2017; Waldman et al., 2018),
indicating that gut absorption may be a limiting
factor in rapidly raising R-βHB with βHB-salts.
However, Kesl et al. (2016) found that a βHBsalt+MCT
combination
prolonged
R-βHB
elevation in rats, and this was observed to be a
superior formula. Additionally, it has been
previously reported that MCTs are rapidly
metabolized to R-βHB (Bach et al., 1996; Seaton et
al., 1986) and produce a more robust thermogenic
effect than other dietary fat sources (Mascioli et
al., 1991; Seaton et al., 1986). However, the βHBsalt+MCT combination has never been explored
for
exercise
performance
and
ketone
supplementation has not been applied to a single
intermediate
distance
running
bout.
Consequently, we sought to explore the ability of
a commercially available exogenous ketone
mixture of βHB-salt+MCT to impact physiologic,
metabolic,
perceptional,
and
performance
responses to intermediate distance running
performance in a randomized, cross-over design
in recreational, college-age endurance athletes.
We hypothesized that this βHB-salt+MCT drink
would alter blood metabolites and metabolism,
but neither perception nor athletic performance,
in line with previous work exploring βHB-salt
alone (Evans et al., 2018; O'Malley et al., 2017;
Rodger et al., 2017; Stubbs et al., 2017; Waldman
et al., 2018).

Methods
Experimental Approach to the Problem
A double-blind placebo-controlled crossover design was employed consisting of one
familiarization trial and two experimental trials.
During the familiarization session, participants
were informed of all procedures and familiarized
with all performance measures to reduce the
possibility of a learning effect. The familiarization
trial was identical to experimental trials except
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that participants consumed no supplement prior
to exercise. After familiarization, participants
completed two experimental conditions (ketone or
placebo), the order of which was completed in a
randomized
and
counterbalanced
fashion
separated by 7 days. On experimental days,
participants consumed either 300 mg.kg-1 body
weight of the ketone supplement (βHB-salt+MCT)
or a flavor matched placebo (PLA) 60 min prior to
performing a 5-km running time trial on a
treadmill. Plasma glucose and ketones were
measured at baseline, 60 min post supplement
ingestion, and immediately following the time
trial. Plasma blood lactate concentration was
measured before and after the time trial. Other
variables evaluated were (a) 5-km running time,
(b) RPE (RPE-Overall; RPE-Chest; RPE-Legs), (c)
heart rate, (d) affect, (e) session RPE, (f) session
affect, and (g) 500-m split times during the 5-km
time trial. The RPE, heart rate, and affect were
taken every 500-m during the 5-km time trial. In
addition, during the time trial oxygen uptake
(VO2), carbon dioxide production (VCO2), minute
ventilation (VE) and respiratory exchange ratio
(RER), were assessed and derived from indirect
calorimetry. Testing sessions were conducted at
the same time each day at a room temperature
between 19-210C and a relative humidity of 3540%. All testing took place at the Exercise Science
Laboratory of Grove City College.
Participants
Ten male, recreational runners (age: 20.8 ±
1.03 years; body height: 175.6 ± 4.9 cm; body mass:
68.9 ± 5.6 kg; body fat: 13.4 ± 3.6%; lean body
mass: 59.6 ± 3.1 kg; body mass index: 22.4 ± 1.9
kg/m2; running distance per week: 34.6 ± 5.5 km)
volunteered to participate in this study.
Participants were recruited directly from local
running clubs, and by advertising within the local
community. Included men: (a) currently run an
average of 32 km per week; (b) were between the
ages of 18-35; and (c) had completed a 5-km
distance run under 30 min within the last 3
months. Participants were not currently taking
medications or following a low-carbohydrate or
ketogenic diet, or currently consuming nutritional
ketone supplements. Participants were prohibited
from using any ergogenic aids for one month
preceding the study and were asked to refrain
from taking any performance enhancing
supplement(s) other than the experimental
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beverage during the study. Runners were
instructed not to change their regular exercise
training and dietary habits for the duration of the
study, and they were told not to exercise prior to
testing. Participants were instructed to refrain
from caffeine, and alcohol consumption for 48
hours, physical activity for 24 hours, and food and
drink for 3 hours before each exercise test
(Astorino et al., 2012; Forbes et al., 2007).
Participants were instructed to maintain a training
and dietary log for 3 days before the first
experimental trial. They were provided with a
copy of their pre-trial log, and were instructed to
have the same dietary intake and physical activity
during the 48 hours before the other trials. Dietary
logs were checked to ensure compliance and we
were satisfied that all of the participants adhered
to the instructions given and that the food and
drinks consumed before each trial were the same.
Before enrolling in the investigation, participants
were fully informed of any risks and discomforts
associated with the experiments prior to giving
their written informed consent to participate. The
experimental protocol was approved by the
Institutional Review Board of Grove City College
prior to implementation.
Procedures
Familiarization Testing. At the first
laboratory visit, all the experimental procedures
were explained to the participants. Participants
underwent an orientation involving practice of
treadmill running and familiarization of the
various experimental instruments, equipment,
affect and perceived exertion. Affect was
measured using a validated 11-point Feeling Scale
(Hardy, 1989) with participants informed that
their responses should reflect the affective or
emotional components of the exercise and not the
physical sensation of effort or strain. The OMNI
Walk/Run Perceived Exertion Scale (Robertson et
al., 2004) was used to measure the physical
perceptions of exertion for overall body (RPE-O),
legs (RPE-L) and chest (RPE-C). Following the
orientation session, anthropometric measures
were obtained including body height (cm), body
mass (kg), fat free mass (kg) and fat mass (% and
kg). Body height (cm) was measured using a
physician’s scale (Detecto, Webb City, MO). Body
mass (kg) and body composition (fat and lean
mass) were estimated using a Tanita bioelectrical
impedance analyzer (BIA) (TBF-310GS Tanita

118

Effects of an exogenous ketone supplement on five-kilometer running performance

Corporation of America, Arlington Heights,
Illinois).
Experimental Trials. On experimental
testing days, participants were given either a
commercially available βHB-salt+MCT or a flavormatched PLA. The beverages were served cold (~6
°C) and were provided to participants 60 min
before the test began. Participants were instructed
to drink the beverage within 2 min of receiving it.
To ensure a double-blinded design, each drink
was presented to participants in an opaque sports
bottle. After consumption of the beverage,
participants were instructed to sit quietly for 1
hour.
Before the start of the time trial,
participants completed a 5-min warm-up run on
the treadmill (TMX425C treadmill; Trackmaster,
Newton, KS, USA). Immediately thereafter, the
treadmill was brought to a standstill (0 km∙hr-1).
At this point all timing devices were reset, the
distance covered on the treadmill monitor was
reset, and a 5-s count down was given to signal
that the time trial has begun (Prins et al., 2016).
Participants were instructed to finish the 5-km run
as fast as possible on a motorized treadmill at
0.0% grade. Participants were provided with
feedback on the distance (at regular 500-m
intervals) covered during each 5-km time trial and
were not informed of the overall performance
time until completion of the final testing session.
The heart rate (Polar Electro, Kempele, Finland),
RPE (RPE-Overall; RPE-Chest; RPE-Legs) and
affect (Feeling Scale) were recorded at 500-m
intervals during the time trial. During the time
trial, participants were allowed to adjust their
pace via control buttons located on the treadmill.
The speed indicator was concealed from the
participant’s view throughout the time trial.
Therefore, participants regulated their treadmill
pace according to their perceived exertion
associated with the intensity of the exercise and
their subjective feelings of their running
capabilities. During each treadmill run all timing
devices were removed from the participant’s
sight. Immediately upon cessation of treadmill
exercise, participants estimated their perceived
exertion and affect, and a final heart rate
measurement was taken. Lastly, ratings of
perceived exertion and affect for the entire
exercise session (session RPE and session affect)
were obtained 5 min following the time trial. Gas
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samples were collected throughout the time trial
using a metabolic cart (TrueOne 2400® Metabolic
Measurement System, Parvo Medics, Inc., Sandy,
UT). To establish any learning effect after
completion of the two experimental trials, 5-km
time to completion was compared between the
supplement and the placebo trial using a paired
samples t-test. No significant difference between
trials was observed (p = 0.577). In addition,
intraclass correlation coefficients were computed
for all conditions of all participants of the 5KTT
and was reported to be ICC r = 0.870 with a 95%
confidence interval of 0.584–0.965.
Metabolic Gases. Prior to each 5KTT, opencircuit spirometry was calibrated with room air
and gases of known concentrations, which was
used to estimate VO2 (ml∙kg−1∙min−1) by sampling
and analyzing breath-by-breath expired gases.
Expired gases — VO2, VCO2, VE, and RER, were
monitored continuously during exercise and
expressed as 30-s averages.
Blood Sampling. Finger-tip blood samples
were collected and immediately processed for
plasma blood lactate (Lactate Plus, Nova
Biomedical), ketones (R-βHB; Precision Xtra,
Abbott Diabetes Care Inc., Almeda, CA) and
glucose (Precision Xtra, Abbott Diabetes Care Inc.,
Almeda, CA) concentrations. Fingertip capillary
samples were collected using a lancet following
cleaning with alcohol swab and dried. The first
droplet was wiped away with a cotton swab to
remove any alcohol and the subsequent droplets
were used for analysis. Blood samples were
measured at baseline, 60 min post-supplement
ingestion, and at the end of the time trial.
Supplementation. The supplement used in
this study consisted of βHB-salt+Medium Chain
Triglyceride (KETO//OS 2.1 Orange Dream,
Pruvit, Melissa, TX, USA). Participants consumed
300 mg.kg-1 of body mass of the ketone
supplement powder mixed with approximately
237 ml of cold (~6 °C) water prior to ingestion.
The supplement contained a calculated 9.0 βHB
racemic salt (50% R-βHB and 50% S-βHB) and
reported 7g MCT. A complete list of the
ingredients and the relative dose of each
ingredient is provided in Table 1. Volume for the
drinks was measured with a graduated cylinder
and the dry ingredients were measured to the
nearest 0.001 g on a calibrated balance scale
(Denver Instrument, Bohemia, NY). When

http://www.johk.pl

119

by Philip J. Prins et al.
receiving the PLA, participants consumed an
equal amount of water with MiO Orange
Tangerine Liquid Enhancer (0 mg caffeine, 0 kcal;
Kraft Foods; MiO, Northfield, IL, USA). The
ketone supplement, and PLA drink were similar
in volume, texture, and appearance. The taste of
the drinks was slightly different, and there
remains the possibility that participants were able
to identify the drinks. To avoid the placebo effect
in the experimental trials, we did not inform
participants about the names of the drinks and we
presented both drinks as having similar ergogenic
properties.
Statistical Analysis
Statistical analyses were performed using
SPSS version 24.0 (SPSS Inc., Chicago, IL).
Statistical significance was set a priori at p < 0.05.
Descriptive statistics were calculated for all
variables. Data were tested for normality using
the Shapiro-Wilk test. Performance data (5-km
running time), mean exercise heart rate, RER,
VO2, VCO2, VE, affect, RPE-Chest, RPE-Legs, RPEOverall, session RPE and session affect were
analyzed using a paired-samples t-Test. A 2 × 10
(condition x distance during the 5-km time trial)
repeated measures analysis of variance was
conducted to assess the effect of time, treatment,
and interaction between time and treatment, on
heart rate, affect, RPE-Chest, RPE-Legs, RPEOverall, and time covered at each 500-m interval
during the 5-km time trial. A 2 (condition,
supplement vs placebo) x 3 (rest, 60 min post
ingestion, and at end of exercise) repeated

measures analysis of variance was conducted to
assess the effect of time, treatment, and interaction
between time and treatment, on plasma glucose
and ketones. A 2 x 2 (before and after exercise)
repeated measures analysis of variance was
conducted to assess the effect of time, treatment,
and interaction between time and treatment, on
plasma lactate. The assumption of sphericity was
confirmed using Mauchly's test. GreenhouseGeisser epsilon corrections were used when the
sphericity assumption was violated. Effect sizes
(Cohen’s d) were calculated and interpreted as:
small effect > 2; medium effect > 0.5; large effect >
0.8.

Results
Time Trial Performance
No significant difference (p = 0.100) was
observed between the βHB-salt+MCT supplement
(1430.0 ± 187.7 s) and the PLA (1488.3 ± 243.8 s) in
time to complete the 5KTT (Figure 1; Table 2).
However, in comparison to the mean time for the
PLA trial, βHB-salt+MCT supplement ingestion
resulted in an average non-significant decrease in
time to completion of 58.3 s (4.06%; 95% CI: 130.12 – 13.52; ES = 0.27). The individual range in
reduced time to completion across participants
was 43 - 214 s. Eight participants (80%) ran faster
after consuming the βHB-salt+MCT supplement,
while two participants (20%) ran faster after
consuming the PLA.

Table 1
Ingredients contained in 1 dose of the ketone supplement in absolute serving size
Ingredient
Amount per serving
Total Calories
110 Kcal
β-hydroxybutyrate (βHB)
9.0 g*
Medium-Chain Triglycerides (MCT)
7g
Sodium
1.4 g
Potassium
47 mg
Total Carbohydrates
3g
Sugars
2g
Protein
1g
Data are reported values based on product labeling. Note. * = estimated grams of βhydroxybutyrate (βHB) from 1) calculation of the molecular equivalence of the mineral load
to (βHB) and 2) calculation of the difference between total product weight and non-βHB
ingredient weights.
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Table 2
Physiological, metabolic and perceptual data for 5-km time-trial performance
between the supplement and the placebo (N = 10)
Variable
Ketone
Placebo
p‐value
Effect Size
Supplement
TT performance (s)
1430.0 ± 187.7
1488.3 ± 243.8
0.100
0.27
HR (b.min-1)
173.1 ± 15.7
178.8 ± 7.9
0.322
0.46
RPE- O
5.5 ± 1.3
5.3 ± 1.4
0.593
0.15
RPE- C
5.0 ± 1.4
5.0 ± 1.3
1.000
0.00
RPE- L
5.3 ± 1.5
5.0 ± 1.6
0.434
0.19
Affect
2.3 ± 1.8
1.8 ± 1.8
0.143
0.28
.
-1
VO2 (L min )
3.0 ± 0.5
3.0 ± 0.5
0.665
0.08
VO2 (ml.kg.min-1)
44.2 ± 5.6
43.8 ± 5.9
0.695
0.07
.
-1
VCO2 (L min )
3.0 ± 0.6
2.9 ± 0.6
0.521
0.12
VE (L.min-1)
70.9 ± 14.8
69.4 ± 15.0
0.607
0.10
RER
0.99 ± 0.04
0.98 ± 0.04
0.655
0.24
Session RPE
6.2 ± 1.3
7.3 ± 1.6
0.093
0.76
Session Affect
2.6 ± 1.6
2.0 ± 2.3
0.456
0.3
Data are Mean ± SD. Note. TT = time trial; HR = heart rate; RPE-O = RPE for overall body;
RPE-C = RPE for chest; RPE-L = RPE for legs; RPE = rating of perceived exertion (OMNI rating of
exertion); RER = Respiratory exchange ratio. Effect sizes, < 0.2 = trivial; 0.2 to 0.49 = small;
0.5 to 0.79 = moderate; > 0.8 = large

Figure 1
Mean and individual 5-km performance time following exogenous
ketone supplement and placebo ingestion.
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http://www.johk.pl

by Philip J. Prins et al.

Figure 2
Impact of exogenous ketone supplementation on blood R-β-hydroxybutyrate, glucose, and
lactate. A) Blood R-β-hydroxybutyrate was higher 60 min post-supplement and remained
elevated throughout exercise in the oral ketone condition. B) Blood glucose rose during
exercise but was not affected by oral ketone supplementation. C) Blood lactate rose during
exercise, but was not affected by oral ketone supplementation. Values are Mean ± SD.
(N = 10). *Significant difference between Ketone and Placebo conditions (p < 0.05).
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Physiological, Metabolic and Perceptual
Responses
Blood R-βHB increased from baseline under
the βHB-salt+MCT condition, and levels were
elevated throughout the entire protocol compared
to the PLA (p < 0.05 for all; Figure 2A). Blood
lactate and glucose concentration rose from
baseline to the end of exercise (p < 0.001), but
there were no significant differences seen between
conditions at any time point (p > 0.05; Figure 2B
and C). Heart rate and RPE (chest, legs, and
overall) increased significantly during exercise (p
< 0.001), while affect deceased significantly during
exercise (p < 0.001), however, there were no
significant effects for treatment for any of the
aforementioned variables (p > 0.05). In addition,
no significant differences between the βHBsalt+MCT supplement and the PLA were
observed for average HR (173.1 ± 15.7 and 178.8 ±
7.9 bpm, respectively; p = 0.322; ES = 0.46), average
VO2 (3.0 ± 0.5 and 3.0 ± 0.5 L.min-1, respectively; p
= 0.665; ES = 0.08), average VCO2 (3.0 ± 0.6 and 2.9
± 0.6 L.min-1, respectively; p = 0.521; ES = 0.12),
average RER (0.99 ± 0.04 and 0.98 ± 0.04,
respectively; p = 0.655; ES = 0.24), average VE (70.9
± 14.8 and 69.4 ± 15.0 L.min-1, respectively; p =
0.607; ES = 0.10), average affect (2.3 ± 1.8 and 1.8 ±
1.8, respectively; p = 0.143; ES = 0.28), average
RPE-O (5.5 ± 1.3 and 5.3 ± 1.4, respectively; p =
0.593; ES = 0.15), average session RPE (6.2 ± 1.3
and 7.3 ± 1.6, respectively; p = 0.093; 0.76), and
average session affect (2.6 ± 1.6 and 2.0 ± 2.3,
respectively; p = 0.456; ES = 0.30) (Table 2).

Discussion
The purpose of this study was to
determine whether a commercially available
exogenous ketone mixture of βHB-salt+MCT
would
impact
physiologic,
metabolic,
perceptional, and performance responses to
intermediate distance running performance in
recreational, college-age endurance athletes. We
hypothesized that the βHB-salt+MCT drink
would alter blood metabolites and metabolism,
but neither perception nor athletic performance.
This is the first study to examine the effect of a
commercially available ketone supplement on 5km running performance in recreational male
distance runners. The major finding of this study
was that ingesting 300mg.kg-1 body mass of an
βHB-salt+MCT drink 60 min before exercise
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resulted in a non-significant 4.06% improvement
in 5-km treadmill running time (p = 0.100).
Furthermore, low variability of 5-km time trials
established in our laboratory and among
endurance-trained distance runners (typical error
of measurement of 31.75 s with a coefficient of
variation of 2.18%) suggests that altered
endurance performance likely resulted from the
ketone supplement ingestion (Prins et al., 2016).
Additional analysis did show significant
differences in circulating R-βHB, with no
differences in other metabolic, physiologic, and
perception variables. Together, results indicate a
mixed response across participants after
consuming
300
mg.kg-1
βHB-salt+MCT
supplement prior to exercise with 80% deemed
responders and 20% non-responders.
Exogenous ketone supplements have
emerged as a powerful and viable tool for
regulating metabolism. Exogenous ketone
formulations have been shown to safely raise
circulating ketone levels and alter blood glucose
(Kesl et al., 2016). This analysis looked at βHBsalt, MCT, βHB-salt+MCT, ketone ester, and 1,3butanediol, demonstrating differential metabolic
responses across the various exogenous ketone
formulations tested. Ketone esters are widely
considered the most potent exogenous ketone
supplement and various agents are starting to
enter the commercial market. 1,3-butanediol
acetoacetate diester, a ketone ester, has recently
been shown to reduce body mass and adiposity in
obese mice, supporting the idea that ketones
change energy metabolism (Davis et al., 2018).
MCTs are naturally occurring in a variety of
animal and vegetable fat, but can be consumed in
a supplemental form. MCTs are ingested, shuttled
to the hepatocyte inner mitochondrial membrane,
and readily converted to R-βHB since they do not
require carnitine to undergo β-oxidation (Bach et
al., 1996; Sarda et al., 1987). βHB-salts are typically
in a racemic mixture of 50% R-βHB and 50% SβHB (Stubbs et al., 2017). To synthesize these
molecules, βHB is ionically bound to monovalent
or divalent cations (Na+, K+, Mg2+, Ca2+) to create a
salt. Thus, βHB-salts accompany a mineral load
depending on the choice and proportion of cation
used to synthesize the salt. Upon ingestion, βHBsalts are absorbed through intestinal MCT
transporters and enter systemic circulation where
they can be readily metabolized in extra-hepatic
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tissue. S-βHB appears to undergo differential
metabolic pathways than R-βHB (Desrochers et
al., 1992; Stubbs et al., 2017, 2018) but does have
some similar signaling capabilities (Newman and
Verdin, 2017). βHB-salt+MCT extends the
circulating elevation of R-βHB further than when
βHB-salt-only is administered (Kesl et al., 2016).
Unsurprisingly,
βHB-salt+MCT
significantly elevated circulating R-βHB levels 2fold (0.3 to 0.6 mM) in our findings. Similar
elevations in circulating R-βHB have been seen in
other trials with βHB-salt supplementation (Evans
et al., 2018; O'Malley et al., 2017; Rodger et al.,
2017; Stubbs et al., 2017; Waldman et al., 2018).
However, total βHB levels reported across these
trails and ours, underestimate the total circulating
βHB levels, as S-βHB is undetectable by current
meter and bench top assay kits (Evans et al., 2018;
O'Malley et al., 2017; Rodger et al., 2017;
Waldman et al., 2018) and requires mass spectrum
analysis (Stubbs et al., 2018). Stubbs et al. (2017)
demonstrated that when a racemic βHB-salt
compound is orally administered, both R-βHB
and S-βHB become elevated, but S-βHB is
elevated to a higher degree due to its believed
delayed metabolism. Thus, our results and others
using βHB-salts underestimate total βHB (Evans
et al., 2018; O'Malley et al., 2017; Rodger et al.,
2017; Waldman et al., 2018). While knowing total
βHB is important for predicted systemic effect
and cellular signaling, S-βHB is not fully
metabolized through the ketolysis pathway and
may not be consequential on the energetics of
exercise performance in the present study (Stubbs
et al., 2018). S-βHB may play an important role in
signaling that is being investigated for its
protective effects (Newman and Verdin, 2017).
R-βHB elevations were observed in all
studies involving βHB-salts (Evans et al., 2018;
O'Malley et al., 2017; Rodger et al., 2017; Stubbs et
al., 2017; Waldman et al., 2018), including our
present findings, but were substantially lower
than those achieved via ketone esters (Cox et al.,
2016; Evans and Egan, 2018; Leckey et al., 2017;
Stubbs et al., 2017). Additionally, serum glucose
levels did not substantially change in the current
study compared to the placebo, a finding that has
been previously reported with ingestion of βHBsalts (Rodger et al., 2017; Waldman et al., 2018).
However, this is not consistently reported
(O'Malley et al., 2017; Stubbs et al., 2017). Lactate

© Editorial Committee of Journal of Human Kinetics

123
is a substrate biomarker for glycolytic metabolism
and is commonly elevated post-exercise. Initial
report on ketone ester ingestion demonstrated
lower lactate production during exercise (Cox et
al., 2016), which was confirmed by two
subsequent analyses of various ketone ester
formulations (Evans and Egan, 2018; Leckey et al.,
2017). However, this is dissimilar to the
augmented (Volek et al., 2016) and neutral effects
(Zajac et al., 2014) reported on exercise lactate
production with VLCKD. Exogenous ketoneinduced attenuated lactate production was
initially proposed as a glucose sparring
mechanism which allowed for glucose to be
present for anaerobic efforts at the end of a race
(Cox et al., 2016). However, others have
speculated on the potential for ketones to
attenuate glucose utilization and subsequent
lactate
production,
potentially
inhibiting
performance (Evans and Egan, 2018; Leckey et al.,
2017). Some argue that this may be a consequence
of changes seen in pyruvate dehydrogenase
activity as has been seen in low-carbohydrate
dietary regimens (Stellingwerff et al., 2006).
However, it is currently unknown whether
changes in pyruvate dehydrogenase activity occur
consistently with acute ketone administration and
whether this will influence performance.
Additionally, an attenuation of lactate production
has not been reported in any trial using βHB-salts
(Evans et al., 2018; O'Malley et al., 2017; Rodger et
al., 2017; Waldman et al., 2018), which agrees with
our findings and those by Zajac et al. (2014) using
a VLCKD. Taken together, our metabolic data
indicate that consumption of βHB-salt+MCT
results in significantly elevated circulation of
βHB, a finding that is reported across all
exogenous ketone supplements (Stubbs et al.,
2017; Leckey et al., 2017). However, we did not
find changes in blood glucose levels, which is
consistent with some reports using βHB-salt
(Rodger et al., 2017; Waldman et al., 2018), and
inconsistent with others (O'Malley et al., 2017;
Stubbs et al., 2017). Together, these results
indicate mixed results on the blood glucose
lowering effects of βHB-salt administration.
Additionally, the unchanged lactate levels
reported in the present study indicate that higher
levels of circulating ketones may be required to
attenuate lactate production, an effect that has
been seen with more potent forms of exogenous
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ketone administration (Cox et al., 2016; Evans and
Egan, 2018; Leckey et al., 2017), but not found in
βHB-salt administration (Evans et al., 2018;
O'Malley et al., 2017; Rodger et al., 2017;
Waldman et al., 2018). Interestingly, the
augmented (Volek et al., 2016) and neutral effects
(Zajac et al., 2014) of a VLCKD on exercise lactate
production highlight potential metabolic overlap
and discrepancies between a VLCKD and various
exogenous ketone formulations.
Substrate
utilization
is
commonly
extrapolated from the amount of O2 consumed
and CO2 expelled (Jeukendrup and Wallis, 2005).
Previous analyses of βHB-salt under such
calculations were extrapolated to indicate that
βHB-salts may increase fat-oxidation (O'Malley et
al., 2017). However, such assumptions during
ketone supplementation without adjustment
calculations may not be valid (Evans and Egan,
2018). Equating substrate utilization from RER
measurements cannot be reliably done without
adjusting calculations for ketone supplementation
as RER of βHB and AcAc are 0.89 and 1.00,
respectively, directly confounding calculations of
glucose and fat oxidation (Frayn, 1983). Thus,
substrate level utilization cannot be determined
from the present study or others testing βHB-salts
(O'Malley et al., 2017). Additionally, while RER
was not significantly different within the current
study, RER has had inconsistent results in
previous analysis involving βHB-salts with some
indicating lower RER (O'Malley et al., 2017), and
some indicating higher (Evans et al., 2018; Rodger
et al., 2017).
Finally, we did not find a performanceenhancing effect across the mean of all 10
participants, although a non-significant decrease
in time to completion of 4.06% (~60 seconds) was
observed (p = 0.100). To date, only three studies
have analyzed βHB-salts as an ergogenic or
ergolytic supplement in performance outcomes:
1. a 15-min staged exercise regimen prior to
a 10 km cycling time trial (O'Malley et al.,
2017).
2. a 90 min steady-state bout of cycling at
80% of the ventilatory threshold, followed
by a 4-km time trial (Rodger et al., 2017)
3. a 5 min warm up prior to four 15 s
maximum effort intervals (Waldman et
al., 2018).
Two of the three trials showed no
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difference when aerobic activity was used prior to
an analyzed intense anaerobic environment
thereafter, both using various cycling exercise
regimens (Rodger et al., 2017; Waldman et al.,
2018). However, one of the trials showed a 6.9%
slower time and 7% lower power output during
time trial completion using graded cycling
exercise (30%, 60%, 90% of ventilatory threshold)
followed by a measured 10-km time trial
(O'Malley et al., 2017), with two subjects
performing worse. However, our data indicate a
mixed response across participants consuming the
βHB-salt+MCT combination.
One potential explanation for the
alternative response reported is the type of
exercise regimen utilized in the present analysis,
i.e., running. Alternatively, all previous analysis
into βHB-salts with neutral or negative effects
utilized cycling as exercise of choice (O'Malley et
al., 2017; Rodger et al., 2017; Waldman et al.,
2018), indicating potential supplemental sport
ergogenic specificity. A more likely explanation
for the result discrepancy in the present trial is the
lack of preliminary exhaustive exercise prior to
the 5-km time trial. The likely rational for
providing exhaustive exercise prior to a time trial
performance is to replicate the race environment
where the final stretch of the race requires all out
(timed) effort and thus can have influence on the
final race performance and finish. Experimental
designs may also be influenced by the original
work done in cyclists using the ketone ester which
involved a preliminary steady state exercise
regimen for 60 min followed by a 30-min time
trial (Cox et al., 2016). Additionally, the original
analysis of ketone ester supplementation
indicated that >1.0 mM elevations in ketone may
attenuate glucose utilization or be glycogen
sparring (Cox et al., 2016). However, glucose
sparing effect of ketones only appears to happen
in the context of ketone ester as they all have
shown attenuated lactate production (Cox et al.,
2016; Evans and Egan, 2018; Leckey et al., 2017).
Lastly, we cannot exclude the possibility that this
unique formulation contributed to discrepant
performance outcomes when compared with pure
racemic βHB-salts as this βHB-salt+MCT
formulation contains a higher percentage of RβHB precursors (Kesl et al., 2016), has shown to
produce a more prolonged elevations in
circulating serum R-βHB in rodents, and all
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historical R-βHB analyses in exercised human
cohorts demonstrating similar R-βHB elevations
are limited to timepoint measurements and not
total R-βHB exposure over study duration
(O'Malley et al., 2017; Rodger et al., 2017;
Waldman et al., 2018).
Limitations of the present study include
the method of plasma metabolite analysis,
inability to differentiate this supplement used
against other fueling strategies, and the inability
to directly measure tissue substrate utilization to
determine tissue specific effects. Discrepancies
have been observed across handheld meters and
bench top assays, neither of which assessed total
βHB levels in the blood. Mass spectrum analysis
is the only method currently available to
determine S-βHB and total βHB. The present
study was conducted to determine the ergolytic or
ergogenic influence of a specific formula of βHBsalts+MCT. Consequently, we are unable to
determine whether supplementing with βHBsalts+MCT is superior to other known athletic fuel
strategies. Lastly, RER measurements are
traditionally used to determine fat to
carbohydrate
oxidation.
However,
ketone
supplementation confounds these measurements
and would require a combination of ketone
excretion and blood ketone measurements to

estimate influence of ketones on substrate level
oxidation.

Conclusions
Traditionally, ketosis was only achieved through
dietary manipulation. Recent interest has arisen to
develop ketone bodies that can be exogenously
administered without dietary carbohydrate
restriction. With the emergence of commercially
available
exogenous
ketone
formulations,
research has focused on exploring their use in
athletic performance. To our knowledge this is the
first study to report the effects of oral ketone
supplement ingestion on 5-km treadmill running
performance. This investigation demonstrated
that recreational endurance athletes consuming a
βHB-salt+MCT formula showed a non-significant
4.06% decrease in time to complete volitional 5km run performance (p = 0.100). βHB-salt+MCT
consumption did significantly increase blood RβHB levels, with no differences in other
metabolic, physiologic, and perception variables.
Results indicate that runners may experience
mixed responses to consuming a 300 mg.kg-1 βHBsalt+MCT supplement prior to exercise. Further
testing will be needed to determine if βHBsalts+MCT provides a unique metabolic
advantage, and if this altered response is specific
to the exercise task.
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